• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr Ali McBride Discusses the Role of Biosimilars in Oncology

Video
Conference|ACCC: Association of Cancer Care Centers

At the Association of Community Cancer Centers (ACCC)'s 45th Annual Meeting & Cancer Center Business Summit, Ali McBride, PharmD, MS, BCPS, BCOP, clinical coordinator of hematology/oncology in the Department of Pharmacy at The University of Arizona Cancer Center and president of ACCC, discussed the role of biosimilars in oncology and how familiar oncologists and their teams are with them.

At the Association of Community Cancer Centers (ACCC)'s 45th Annual Meeting & Cancer Center Business Summit, Ali McBride, PharmD, MS, BCPS, BCOP, clinical coordinator of hematology/oncology in the Department of Pharmacy at The University of Arizona Cancer Center and president of ACCC, discussed the role of biosimilars in oncology and how familiar oncologists and their teams are with them.

Related Videos
Dr Eric H. Yang
Dr Debra Patt
Steven Manobianco, MD
Dr Yara Abdou
Xiaotong Li, PhD, MS, Memorial Sloan Kettering Cancer Center
Dr Amrita Basu
Justin Drake, PhD
Joanna Rhodes, MD, MSCE, director of the lymphoma program at the Rutgers Cancer Institute and the assistant head of lymphoma at Robert Wood Johnson Medical School
Dr Adam Brufsky
Ira Zackon, MD, senior medical director, Ontada
Related Content
AACR 2025

ICYMI: Highlights From AACR 2025

December 14th 2025
Article

From immunotherapy breakthroughs to early-stage scientific advances shaping the next generation of cancer care, these were the top oncology stories from AACR.

Read More

The Center for Biosimilars podcast banner

Follow the Science: Bridging the Biosimilar Gap With Dr Hillel Cohen

July 29th 2025
Podcast

Listen

ICYMI: Highlights From ACCC 2025

ICYMI: Highlights From ACCC 2025

December 12th 2025
Article

Artificial intelligence and lung cancer highlighted the top conference coverage from the Association of Cancer Care Centers Annual Meeting in Washington, DC.

Read More

Managed Care Cast

Navigating Risk, Treatment, and Reimbursement in Precision Oncology: Sadie Dobrozsi, MD

July 15th 2025
Podcast

Sadie Dobrozsi, MD, of Evolent, discusses how predictive genomics is pushing cancer care into a new era of personalization

Listen

Genes | Image Credit: CrazyJuke - stock.adobe.com

Genetic Insights Shape Personalized Breast Cancer Management, Yet Variant Classification Uncertainty Persists

December 11th 2025
Article

Genetic risk models and variant tools help to guide intensive interventions for high-risk carriers and personalized management for others.

Read More

blood cells - keetazalay - stock.adobe.com.jpg

Ianalumab Shows Disease-Modifying Potential for Early ITP in the Phase 3 VAYHIT2 Trial

December 11th 2025
Article

Adding ianalumab to eltrombopag significantly prolongs time to treatment failure, boosts 6-month response rates, and improves fatigue for adults with primary ITP.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.